1. Alpha4 Integrin blockade in inflammatory bowel disease;Ghosh;Annals of the Rheumatic Diseases,2003
2. Natalizumab for active Crohn's disease;Ghosh;New England Journal of Medicine,2003
3. Quality of life improvements in a phase 2 study of natalizumab for active Crohn's disease;Rutgeerts;Gastroenterology,2003
4. A randomised, double-blind, placebo-controlled, pan-European study of a recombinant humanised antibody to α4 integrin (AntegrenTM) in moderate to severely active Crohn's disease;Letchworth United;Gastroenterology,2001
5. Randomised double blind placebo controlled trial of recombinant humanised antibody to a4 integrin (AntegrenTM) in active Crohn's disease;Gordon;Gastroenterology,1999